Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Monster Beverage
MNST
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Other financials
Income statement
See full
Revenue
$2.4B
+26.9%
Gross profit
$1.3B
+23.4%
Operating income
$730.0M
+28.1%
Net income
$569.5M
+28.6%
EPS (diluted)
$0.58
+28.9%
Balance sheet
See full
Cash & equivalents
$2.0B
+7.2%
Total debt
$260.6M
+321%
Total equity
$8.7B
+33.9%
Total assets
$10.8B
+31.8%
Cash flow
See full
Operating cash flow
$605.0M
+19.2%
CapEx
$20.6M
-29.1%
Free cash flow
$584.4M
+22.1%
Valuation
See full
Market cap
$93.72B
+52.3%
P/E
46.1×
+5.4×
P/S
10.7×
+2.4×
Profitability
See full
Gross margin
55.5%
+0.8pp
Operating margin
29.3%
+3.0pp
Net margin
23.1%
+2.8pp
FCF margin
23.6%
-0.6pp
Returns & leverage
See full
Return on equity
26.7%
+6.7pp
Debt / equity
0×
0.0×
Current ratio
3.3×
-0.1×